1337 related articles for article (PubMed ID: 22801442)
21. Hereditary angioedema with normal C1 inhibitor and factor XII mutation: a series of 57 patients from the French National Center of Reference for Angioedema.
Deroux A; Boccon-Gibod I; Fain O; Pralong P; Ollivier Y; Pagnier A; Djenouhat K; Du-Thanh A; Gompel A; Faisant C; Launay D; Bouillet L
Clin Exp Immunol; 2016 Sep; 185(3):332-7. PubMed ID: 27271546
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and safety of recombinant human C1-inhibitor for the treatment of attacks of hereditary angioedema: European open-label extension study.
Moldovan D; Reshef A; Fabiani J; Kivity S; Toubi E; Shlesinger M; Triggiani M; Montinaro V; Cillari E; Realdi G; Cancian M; Visscher S; Zanichelli A; Relan A; Cicardi M
Clin Exp Allergy; 2012 Jun; 42(6):929-35. PubMed ID: 22909164
[TBL] [Abstract][Full Text] [Related]
23. Hereditary angioedema: a decade of human C1-inhibitor concentrate therapy.
Farkas H; Jakab L; Temesszentandrási G; Visy B; Harmat G; Füst G; Széplaki G; Fekete B; Karádi I; Varga L
J Allergy Clin Immunol; 2007 Oct; 120(4):941-7. PubMed ID: 17761272
[TBL] [Abstract][Full Text] [Related]
24. Recent advances in the management of hereditary angioedema.
Hemperly SE; Agarwal NS; Xu YY; Zhi YX; Craig TJ
J Am Osteopath Assoc; 2013 Jul; 113(7):546-55. PubMed ID: 23843378
[TBL] [Abstract][Full Text] [Related]
25. C1-inhibitor concentrate for individual replacement therapy in patients with severe hereditary angioedema refractory to danazol prophylaxis.
Kreuz W; Martinez-Saguer I; Aygören-Pürsün E; Rusicke E; Heller C; Klingebiel T
Transfusion; 2009 Sep; 49(9):1987-95. PubMed ID: 19497056
[TBL] [Abstract][Full Text] [Related]
26. Chapter 22: Hereditary and acquired angioedema.
Georgy MS; Pongracic JA
Allergy Asthma Proc; 2012; 33 Suppl 1():73-76. PubMed ID: 22794695
[TBL] [Abstract][Full Text] [Related]
27. HEREDITARY ANGIOEDEMA DUE TO C1-INHIBITOR DEFICIENCY IN PEDIATRIC PATIENTS IN CROATIA - FIRST NATIONAL STUDY, DIAGNOSTIC AND PROPHYLACTIC CHALLENGES.
Karadža-Lapić L; Barešić M; Vrsalović R; Ivković-Jureković I; Sršen S; Prkačin I; Rijavec M; Cikojević D
Acta Clin Croat; 2019 Mar; 58(1):139-146. PubMed ID: 31363336
[TBL] [Abstract][Full Text] [Related]
28. Unnecessary Abdominal Surgeries in Attacks of Hereditary Angioedema with Normal C1 Inhibitor.
Gutierrez M; Veronez CL; Rodrigues Valle SO; Gonçalves RF; Ferriani MPL; Moreno AS; Arruda LK; Aun MV; Giavina-Bianchi P; Alonso MLO; Pesquero JB; Grumach AS
Clin Rev Allergy Immunol; 2021 Aug; 61(1):60-65. PubMed ID: 33755867
[TBL] [Abstract][Full Text] [Related]
29. Long-term prophylaxis of hereditary angioedema with a pasteurized C1 inhibitor concentrate.
Tallroth GA
Int Arch Allergy Immunol; 2011; 154(4):356-9. PubMed ID: 20975289
[TBL] [Abstract][Full Text] [Related]
30. Paternal mosaicism and hereditary angioedema in a Taiwanese family.
Yu TC; Shyur SD; Huang LH; Wen DC; Li JS
Ann Allergy Asthma Immunol; 2007 Oct; 99(4):375-9. PubMed ID: 17941288
[TBL] [Abstract][Full Text] [Related]
31. Comparison of chromogenic and ELISA functional C1 inhibitor tests in diagnosing hereditary angioedema.
Li HH; Busse P; Lumry WR; Frazer-Abel A; Levy H; Steele T; Dayno J; Riedl M
J Allergy Clin Immunol Pract; 2015; 3(2):200-5. PubMed ID: 25609336
[TBL] [Abstract][Full Text] [Related]
32. Pasteurized and nanofiltered, plasma-derived C1 esterase inhibitor concentrate for the treatment of hereditary angioedema.
Bork K
Immunotherapy; 2014; 6(5):533-51. PubMed ID: 24635050
[TBL] [Abstract][Full Text] [Related]
33. The importance of recognizing and managing a rare form of angioedema: hereditary angioedema due to C1-inhibitor deficiency.
Jacobs J; Neeno T
Postgrad Med; 2021 Aug; 133(6):639-650. PubMed ID: 33993830
[TBL] [Abstract][Full Text] [Related]
34. Diagnosis and management of hereditary angioedema: an emergency medicine perspective.
Moellman JJ; Bernstein JA
J Emerg Med; 2012 Aug; 43(2):391-400. PubMed ID: 22285754
[TBL] [Abstract][Full Text] [Related]
35. C1-inhibitor (C1-INH) autoantibodies in hereditary angioedema. Strong correlation with the severity of disease in C1-INH concentrate naïve patients.
Varga L; Széplaki G; Visy B; Füst G; Harmat G; Miklós K; Németh J; Cervenak L; Karádi I; Farkas H
Mol Immunol; 2007 Feb; 44(6):1454-60. PubMed ID: 16750855
[TBL] [Abstract][Full Text] [Related]
36. Hereditary angioedema with normal C1 inhibitor: clinical characteristics and treatment response with plasma-derived human C1 inhibitor concentrate (Berinert
Bouillet L; Boccon-Gibod I; Gompel A; Floccard B; Martin L; Blanchard-Delaunay C; Launay D; Fain O
Eur J Dermatol; 2017 Apr; 27(2):155-159. PubMed ID: 28251901
[TBL] [Abstract][Full Text] [Related]
37. Hereditary angioedema with normal C1 inhibitor in a French cohort: Clinical characteristics and response to treatment with icatibant.
Bouillet L; Boccon-Gibod I; Launay D; Gompel A; Kanny G; Fabien V; Fain O;
Immun Inflamm Dis; 2017 Mar; 5(1):29-36. PubMed ID: 28250922
[TBL] [Abstract][Full Text] [Related]
38. Is there a need for clinical guidelines in the United States for the diagnosis of hereditary angioedema and the screening of family members of affected patients?
Lunn ML; Santos CB; Craig TJ
Ann Allergy Asthma Immunol; 2010 Mar; 104(3):211-4. PubMed ID: 20377110
[TBL] [Abstract][Full Text] [Related]
39. Presentation, diagnosis and treatment of angioedema without wheals: a retrospective analysis of a cohort of 1058 patients.
Mansi M; Zanichelli A; Coerezza A; Suffritti C; Wu MA; Vacchini R; Stieber C; Cichon S; Cicardi M
J Intern Med; 2015 May; 277(5):585-93. PubMed ID: 25196353
[TBL] [Abstract][Full Text] [Related]
40. First case of homozygous C1 inhibitor deficiency.
Blanch A; Roche O; Urrutia I; Gamboa P; Fontán G; López-Trascasa M
J Allergy Clin Immunol; 2006 Dec; 118(6):1330-5. PubMed ID: 17137866
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
